May 06, 2022
Video
Heather McArthur, MD, MPH, discusses the FDA approval of fam-trastuzumab deruxtecan-nxki for second-line treatment in HER2-positive metastatic breast cancer.
May 04, 2022
Article
The investigational RNA interference therapy, ARO-HIF2, reduced levels of hypoxia inducible factor-2 alpha expression and had acceptable tolerability when used in patients with clear cell renal cell carcinoma, according to data from the phase 1b AROHIF21001 trial.
May 03, 2022
Article
Heather McArthur, MD, MPH, discusses key treatment developments in early-stage and metastatic HER2-positive breast cancer and triple-negative breast cancer, plus ongoing research at UT Southwestern Harold C. Simmons Comprehensive Cancer Center.
April 12, 2022
Article
State of Science Summit- Breast Cancer: Chaired by Heather McArthur, MD
April 05, 2022
Article
Research led by UT Southwestern scientists suggests that an investigational drug could restore the ability of some non–small cell lung cancers to respond to an immune checkpoint blockade, a therapy that harnesses the immune system to fight malignant tumors.
April 05, 2022
Article
Patients who develop post–essential thrombocythemia myelofibrosis or post–polycythemia vera myelofibrosis, which are associated with significant symptom burden and bone marrow failure, have limited therapies available for effective treatment.
January 26, 2022
Video
Ruben A. Mesa, MD, discusses the unique characteristics of momelotinib in myelofibrosis.
October 06, 2021
Video
Larry Anderson, MD, PhD, discusses the methods utilized in the phase 2 KarMMa trial in multiple myeloma.
September 16, 2021
Video
Larry Anderson, MD, PhD, discusses the challenges faced with CAR T-cell therapy in patients with multiple myeloma.
September 04, 2021
Video
Amit Singal, MD, discusses the results of a study evaluating the utilization of a mailed surveillance outreach program in hepatocellular carcinoma.
September 04, 2021
Video
Nicole Rich, MD, discusses the prevalence of cachexia in hepatocellular carcinoma.
August 20, 2021
Video
Hans Hammers, MD, PhD,discusses the safety profile of lenvatinib in combination with pembrolizumab in renal cell carcinoma.
August 12, 2021
Article
Neoadjuvant stereotactic radiation followed by radical nephrectomy and thrombectomy is a safe and feasible treatment option for patients with renal cell carcinoma and inferior vena cava tumor thrombus.
June 02, 2021
Video
Hans Hammers, MD, PhD, discusses the potential utility of HIF-2α inhibitors in renal cell carcinoma.
May 12, 2021
Video
Hans Hammers, MD, PhD, discusses the importance of assessing quality of life in renal cell carcinoma.
May 03, 2021
Video
Amy Jones, MD, discusses future research efforts in pancreatic cancer.
May 03, 2021
Video
Syed Kazmi, MD, an oncologist at The University of Texas Southwestern Medical Center, discusses key treatment considerations for young patients with onset colorectal cancer.
April 13, 2021
Article
Syed Kazmi, MD, highlights the go-to regimens for patients with mCRC.
March 19, 2021
Video
Syed Kazmi, MD, discusses the importance of tailoring treatment to different subtypes of colorectal cancer.
March 05, 2021
Video
Amy Jones, MD, discusses factors that can inform frontline treatment selection in pancreatic cancer.